Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignancies

NCT03637764 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
107
Enrollment
INDUSTRY
Sponsor class

Stopped Study was stopped after interim analysis for 4 cohorts (HCC, SCCHN, EOC, and GBM) indicated that the results did not fulfill the preplanned interim analysis criteria to move to Phase 2 stage 2 in all 4 cohorts.

Conditions

Interventions

Sponsor

Sanofi